Amivantamab (JNJ-61186372) induces clinical, biochemical, molecular, and radiographic response in a treatment-refractory NSCLC patient harboring amplified triple EGFR mutations (L8...

by Balmanoukian, A.S, Klempner, S.J, Madison, R., Nagasaka, M., Ou, S.-H.I, Zhang, S.S
Published 2022

A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses

by Chao, J., Chen, H., Chen, Y.-J, D'Apuzzo, M., Fakih, M., Frankel, P., He, T.-F, Klempner, S.J, Lee, P., Solomon, S., Tajon, M.
Published 2022

Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer

by Atkins, K., Burch, M., Chao, J., Cho, M., Gangi, A., Gong, J., Guan, M., Hendifar, A., Kamrava, M., Kim, S., Klempner, S.J, Lin, D.-C, Midthun, L., Osipov, A., Placencio-Hickok, V.R, Waters, K.
Published 2022

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

by Ambrosini, M., Andre, T., Bergamo, F., Chao, J., Chida, K., Cohen, R., Colle, R., Conca, V., Corti, F., Cremolini, C., Curigliano, G., Elez, M.E, Emmett, M., Fakih, M., Fenocchio, E., Fucà, G., Garciá, M.D, Jayachandran, P., Kawazoe, A., Klempner, S.J, Lonardi, S., Mazzoli, G., Overman, M., Pietrantonio, F., Provenzano, L., Randon, G., Salati, M., Salvatore, L., Shah, A.T, Shitara, K., Svrcek, M.
Published 2022